Studies have identified ADAM10 as the primary sheddase of CD23, a molecule of relevance in CLL, and have implicated its role in Notch signaling, a pathway frequently dysregulated in various cancers, including leukemia (14). This evidence concerns the gene ADAM10 and cancer.